retatrutide vs zepbound vs. Ozempic: The Triple Agonist That May Change Everything., Semaglutide hits one receptor. Retatrutide hits three., That difference may be the biggest leap in metabolic medicine since , Meet Retatrutide: The Unapproved Cousin

The SUPRPASS-4 trial (262), involving 2002 participants with high-risk cardiovascular profiles followed for up to 104 weeks, showed no difference in 4-MACE events (cardiovascular death, myocardial infarction, stroke, and hospitalization for unstable angina) with tirzepatide compared to insulin glargine (HR 0.74

Differences in study methodology, coding reliability, follow-up duration and systemic comorbidities continue to complicate interpretation.

Researchers focused on GLP-1, a naturally occurring hormone released in the gut after eating, because of its ability to stimulate insulin secretion in a glucose-dependent manner and suppress excess glucagon

In August 2023, Marrero ended up in the hospital with abdominal pain, nausea, vomiting, difficulty swallowing and rectal bleeding